Stocklytics Platform
Asset logo for symbol STAA
STAAR Surgical Co
STAA60
$30.43arrow_drop_down0.84%-$0.26
Asset logo for symbol STAA
STAA60

$30.43

arrow_drop_down0.84%
Key Stats
Open$30.92
Prev. Close$31.06
EPS0.33
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
LOWHIGH
Day Range29.83
31.28
52 Week Range26.66
52.68
Ratios
EPS0.33
Fundamentals
Payout Ratio-
Industry average yield2.84%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

STAA-
US Healthcare Sector-
US Market-
check_circle

STAA / Market

STAA exceeded the US Market which returned 0.31% over the last twenty four hours.
warning

STAA / Healthcare Sector

STAA lose to the US Healthcare sector which returned 3.04% over the last twenty four hours.

STAAR Surgical Co (STAA) Statistics

STAAR Surgical Co (STAA) is a company that specializes in the development, manufacturing, and marketing of implantable lenses. The company operates in the healthcare sector and is focused on providing innovative solutions for the treatment of vision disorders. STAA stock is listed on the NASDAQ exchange under the ticker symbol STAA.
When it comes to valuation metrics, STAAR Surgical Co has a current market capitalization of $5.78 billion. The company has a price-to-earnings (P/E) ratio of 165.19, which indicates that the stock may be overvalued. In terms of fundamentals, the company has a return on equity (ROE) of 19.62%, indicating that it is generating a healthy return for its shareholders.
add STAAR Surgical Co to watchlist

Keep an eye on STAAR Surgical Co

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has STAAR Surgical Co (STAA) stock's performance compared to its sector and the market over the past year?

Over the past year, STAAR Surgical Co (STAA) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 37.77%, STAAR Surgical Co has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 74.16%, it has fallen short of the market average. This comparison highlights STAAR Surgical Co's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of STAAR Surgical Co (STAA) stock?

The PE (Price to Earnings) ratio of STAAR Surgical Co (STAA) is currently 92.23. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help

What is the EPS of STAAR Surgical Co (STAA) stock?

The Earnings Per Share (EPS) for STAAR Surgical Co (STAA), calculated on a diluted basis, is $0.33. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of STAAR Surgical Co (STAA) stock?

The operating margin for STAAR Surgical Co (STAA) is 12.08%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of STAAR Surgical Co (STAA) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of STAAR Surgical Co (STAA) is $37.03M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does STAAR Surgical Co (STAA) have?

STAAR Surgical Co (STAA) has a total debt of $36.27M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$156.5M.

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level